Anodic polarographic determination of lansoprazole and omeprazole in pure form and in pharmaceutical dosage forms

Journal of Food and Drug Analysis

Volumn 12, Issue 2, 2004, Pages 102-109

  Belal, Fathalla ^a   El Enany, Nahed ^b   Rizk, Mohamed ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Anodic current mode; Dosage forms; Lansoprazole; Omeprazole; Polarography

Indexed keywords

BUFFER; LANSOPRAZOLE; OMEPRAZOLE;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL PULSE POLAROGRAPHY; DIFFUSION; DRUG CAPSULE; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG PURITY; DRUG STRUCTURE; ELECTRODE; PH; POLAROGRAPHY; RELIABILITY; TABLET FORMULATION;

EID: 4444236762     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Parfitt, K. editor, Martindale, 1999. "The Complete Drug Reference". 32nd ed. pp. 1196, 1204. The Pharmaceutical Press. Massachusetts, U. S. A.
2. Moustafa, A. A. M. 2000. Spectrophotometric method for the determination of lansoprazole and pantoprazole sodium sesquihydrate. J. Pharm. Biomed. Anal. 22 (1): 45-58.
3. Ozaltin, N. 1999. Determination of lansoprazole in pharmaceutical dosage forms by two different spectroscopic methods. J. Pharm. Biomed. Anal. 20 (3): 599-606.
4. Tivesten, A., Folestad, S., Schonbacher, V. and Svensson, K. 1999. Non aqueous capillary electrophoresis for the analysis of labile pharmaceutical compounds. Chromatographia 49 (I): S7-S11.
5. Ekpe, A. and Jacobsen, T. 1999. Effect of various salts on the stability of lansoprazole, omeprazole and pantoprazole as determined by high-performance liquid chromatography. Drug Dev. Ind. Pharm. 25(9): 10571065.
6. Borner, K., Borner, E. and Lode, H. 1998. Separation of lansoprazole enantiomers in human serum by HPLC. Chromatographia. 47 (3-4): 171-175.
7. Borner, K., Borner, E. and Lode, H. 1997. Quantitative determination of lansoprazole in human serum by HPLC. Chromatographia 45: 450-452.
8. Pandya, K. K., Mody V. D., Satia, M. C., Modi, I. A. Modi, R. I., Chakravarthy, B. K. and Gandhi, T. P. 1997. High-performance thin- layer-chromatographic method for the detection and determination of lansoprazole in human plasma and its use in pharmacokinetic studies. J. Chromatogr. Biomed. Appl. 693(1): 199-204.
9. Li, Y. M., Chen, L. Y., Ma, L. J. and Zhang, Q. Y. 1996. HPLC determination of lansoprazole in human plasma. Yaowu- Fenxi -Zazhi 16(4): 252-254.
10. Karol, M. D., Granneman, G. R. and Alexander, K. 1995. Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 668 (1): 182-186.
11. Delhotal Landes, B., Miscoria, G. and Flouvat, B. 1992. Determination of lansoprazole and its metabolites in plasma by high-performance liquid chromatography using a loop column. J. Chromatogr. Biomed. Appl. 577(1): 117-122.
12. Aoki, I., Okumura, M. and Yashiki, T. 1991. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine. J. Chromatogr. Biomed. Appl. 571(1-2): 283-290.
13. El-Zehouri, J. and Madi, S. 2001. Polarographic method for the determination of lansoprazole in dosage form and spiked human urine. Saudi. Pharm. J. 9: 99.
14. Ozaltin, N. and Kocer, A. 1997. Determination of omeprazole in pharmaceuticals by derivative spectroscopy. J. Pharm. Biomed. Anal. 16(2): 337-342.
15. Sastry, C. S. P., Naidu, P. Y. and Murty, S. S. N. 1997. Spectrophotometric methods for the determination of omeprazole in bulk form and pharmaceutical formulations. Talanta 44 (7): 1211-1217.
16. Karljikovic-Rajic, K., Novovic, D., Marinkovic, V. and Agbaba, D. 2003. First order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities. J. Pharm. Biomed. Anal. 32 (4-5): 1019-1027.
17. Salama, F., El-Abasawy, N., Abdel Razeq, S. A., Ismail, M. M. F. and Fouad, M. M. 2003. Validation of spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates. (In Press).
18. Altria, K. D., Bryant, S. M. and Hadgett, T. A. 1997. Validation of capillary electrophoresis method for the analysis of a range of acidic drugs and excipients. J. Pharm. Biomed. Anal. 15(8): 1091-1101.
19. Eberle, D., Hummel, R. P. and Kuhn, R. 1997. Chiral resolution of pantoprazole sodium and related sulfoxides by complex formation with bovine serum albumin in capillary electrophoresis. J. Chromatogr. 759 (12): 185-192.
20. Pinzauti, S., Gratteri, P., Furlanetto, S., Mura, P., Dreassi, E. and Phan-Tan-Luu, R. 1996. Experimental design in the development of voltammetric method for the assay of omeprazole. J. Pharm. Biomed. Anal. 14 (8-10): 881-889.
21. Ozaltin, N. and Temizer, A. 1994. Differential-pulse-polarographic determination of omeprazole in pharmaceutical preparations. Electroanalysis 6 (9): 799-803.
22. Mcclean, S., Okane, E., Ramachandran, V. N. and Smyth, W. F. 1994. Differential-pulse-polarographic study of the degradation of hydrogen ion/potassium ion ATPase inhibitors skandF 95601 and omeprazole in acidic media and the subsequent reaction with thiols. Anal. Chim. Acta. 292 (1): 81-89.
23. Oelschlaeger, H. and Knoth, H. 1998. Polarographic analysis of omeprazole formulations. Pharmazie 53 (4): 242-244.
24. Yeung, P. K. F., Little, R., Jiang, Y., Buckley, S. J. Pollak, P. T., Kapoor, H. and Veldhuyzen-van-zanten, S. J. O. 1998. A simple high-performance liquid chromatography assay for simultaneous determination of omeprazole and metronidazole in human plasma and gastric fluids. J. Pharm. Biomed. Anal. 17 (8): 1393-1398.
25. Xu, X. P., Dai, C. Z. and Li, T. 1997. Studies on chromatographic optimization and its application in pharmacokinetics research. Fenxi. Ceshi. Xuebao. 16 (2): 48-53.
26. Gangadhar, S., Kumar, G. S. R. and Rao, M. N. V. S. 1997. Reverse phase high-performance liquid chromatography assay of omeprazole in plasma. Indian Drugs 34 (2): 99-101.
27. Macek, J., Ptacek, P. and Klima, J. 1997. Determination of omeprazole in human plasma by high-performance liquid chromatography. J. Chromatogr. B 689 (1): 239-243.
28. Katsuki, H., Hamada, A., Nakamura, C., Arimori, K. and Nakano, M. 2001. High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes. J. Chromatogr. Biomed. Appl. 757(1): 127-133.
29. Dogrukol, A. K. D., Tunalier, Z. and Tuncel, M. 1998. TLC densitometric determination of omeprazole in pharmaceutical preparations. Pharmazie 53 (4): 272-273.
30. Radi, A. 2003. Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode. J. Pharm. Biomed. Anal. 31 (5): 1007-1012.
31. McClean, S., Okane, E., Ramachandran, V. N. and Smyth, W. F. 1994. Differential pulse polarographic study of the degradation of H+/K+ ATPase inhibitor SK&F 95601 and omeprazole in acidic media and the subsequent reaction with thiols. Anal. Chim. Acta. 292: 81-89.
32. Heyrovsky, J. and Zuman, P. 1968. "Practical Polarography". pp. 163, 179. Academic Press. New York, U. S. A.
33. Meites, L. and Israel, Y. 1961. The calculation of electrochemical kinetic parameters from polarographic current potential curves. J. Am. Chem. Soc. 83: 4903.
34. Heyrovsky, J. and Kuta, J. 1965. Principles of Polarography Czechoslovak. p. 82 Academy of Science. Prague.
35. Belal, F., Abdine, H. and Zoman, N. 2002. Anodic polarographic determination of nilvadipine in dosage forms and spiked human urine. Mikrochim. Acta. 140: 21-27.
36. Caulcut, R. and Boddy, R. 1983. Statistics for Analytical Chemists Chapman and Hall. London, U. K.